Table 2 Risk factors for overall survival using univariate multivariate analysis in patients with EC underwent RT
From: Role of a multidisciplinary team in administering radiotherapy for esophageal cancer
Variables | univariate | multivariate | ||||
|---|---|---|---|---|---|---|
P | OR | 95%CI | P | OR | 95%CI | |
Age(y) | 0.107 | |||||
< 60 | 1 | |||||
60–75 | 0.05 | 0.64 | 0.41–1.00 | |||
≥ 75 | 0.917 | 0.97 | 0.53–1.78 | |||
Sex | ||||||
Male | 1 | |||||
Female | 0.056 | 0.51 | 0.26–1.02 | |||
PS | ||||||
0–1 | 1 | |||||
2–3 | 0.001 | 3.72 | 2.01–6.89 | 0.002 | 2.90 | 1.49–5.62 |
Location | ||||||
Neck-Upper | 1 | |||||
Middle-Lower | 0.646 | 1.13 | 0.68–1.88 | |||
Histologic type | ||||||
SCC | 1 | |||||
Adeno or others | 0.517 | 0.76 | 0.33–1.74 | |||
Stage | 0.001 | 0.012 | ||||
I-II | 1 | |||||
III | 0.002 | 2.53 | 1.42–4.51 | 0.004 | 2.37 | 1.31–4.29 |
IV | 0.001 | 4.74 | 2.09–10.75 | 0.017 | 3.05 | 1.22–7.62 |
Differentiation | 0.19 | |||||
I-II | 1 | |||||
III-IV | 0.183 | 1.43 | 0.85–2.42 | |||
unknown | 0.077 | 1.55 | 0.95–2.51 | |||
Treatment modality | ||||||
non-operation | 1 | |||||
With operation | 0.01 | 0.59 | 0.39–0.88 | 0.354 | 0.81 | 0.53–1.26 |
non-MDT | 1 | |||||
With MDT | 0.029 | 0.615 | 0.40–0.95 | 0.019 | 0.59 | 0.38–0.92 |